What are the top selling peptide drugs?
•
4 min read
According to recent pharmaceutical data, several peptide drugs have generated billions in revenue, with Novo Nordisk's Ozempic sales exceeding $18 billion in 2024. The incredible growth of these medications, driven primarily by blockbuster glucagon-like peptide-1 (GLP-1) agonists, has positioned them among the most influential therapeutic agents on the market.
